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Introduction
Osteoarthritis (OA), a leading cause of morbidity and 
disability, carries high socioeconomic costs. In 2004 
arthritis was estimated to cost the United States 
$336 billion, or 3% of gross domestic product [1]. OA is 
by far the most common form of arthritis. With 
increasing obesity and age in the population, a massive 
rise in morbidity and costs attributed to OA is expected. 
While joint replacement is eﬀ ective for treating end-stage 
OA in older people, evaluation of potential disease-
modifying treatments in populations meeting current 
clinical criteria for OA has had limited success. Early 
diagnosis and early treatment strategies in rheumatoid 
arthritis have reduced patient morbidity and associated 
costs in the past decade. New concepts for early diagnosis 
and treatment of pre-osteoarthritic conditions may 
similarly improve outcomes and reduce disability and 
costs for OA, the most prevalent form of arthritis.
Pre-osteoarthritis is a modifi able disease process
Epidemiological and genetic studies of OA indicate that 
many pre-OA disease states can be modiﬁ ed. While OA 
can aﬀ ect any joint, substantial disability is attributed to 
OA of the weight-bearing joints, primarily the hip and 
knee. OA is a multifactorial decades-long process reﬂ ect-
ing a complex interplay between intrinsic and extrinsic 
factors. While there is evidence for heritability of OA 
[2,3], the polygenic nature of the disease with multiple 
genes contributing small eﬀ ects has made it diﬃ  cult to 
identify the genetic etiologies of OA [4]. Genome-wide 
association studies have yielded few common genetic 
targets [5]. Whereas OA is the culmination of multi-
variate interactions between genetic, epigenetic, and 
environ mental factors, extrinsic factors such as obesity, 
trauma, and joint loading patterns are known to heighten 
OA risk and to oﬀ er more deﬁ nable targets for disease 
modiﬁ  cation. Th e systematic study of large cohorts at 
increased risk for accelerated OA development therefore 
has poten tial not only to yield new disease-modifying 
treatments but to facilitate improved understanding of 
the complex interactions between genes and the 
environment in OA development [6].
Extrinsic events such as joint trauma accelerate 
osteoarthritis development
Post-traumatic OA illustrates the concept that modiﬁ able 
extrinsic factors play a substantial role in OA develop-
ment. Joint trauma such as intra-articular fracture, 
dislocations, anterior cruciate ligament tear (ACLT), and 
other injuries lead to rapid joint degeneration in a high 
proportion of patients [7,8]. Articular surface incon gru ity, 
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joint instability, altered kinematics, articular cartilage 
injury, and other joint-tissue changes attributable to the 
traumatic event accelerate OA development. In a long- 
term prospective cohort study, young adults with knee 
injuries showed substantially increased risk for later 
development of osteoarthritis of the index knee [8]. 
Another study showed that roughly one- half of indivi-
duals with ACLTs or meniscus tears developed 
radiographic signs of OA 10 to 20 years after injury [9]. 
Since ACLT is most frequently sustained by teenagers 
and young adults, it can be considered the cause of 
premature knee OA in these patients  – a devastating 
outcome with costly social and economic consequences.
Joint injury cohorts enable characterization of pre-
osteoarthritic processes from the earliest stages
For the study of pre-OA conditions, joint injury cohorts 
oﬀ er the potential to study, characterize, and modify the 
disease process from its earliest stages. A recent 
American Orthopaedic Society for Sports Medicine/
National Institutes of Health U-13 multidisciplinary 
conference focused on post-joint injury OA described 
advantages for studying meniscus-injured and anterior 
cruciate ligament (ACL)-injured cohorts [6]. Th ese 
cohorts represent populations that do not meet the 
classic radiographic or clinical criteria for OA [10]. 
Rather, subjects have joint pathologies placing them at 
risk for accelerated OA development. Th ese populations 
oﬀ er opportunities to deﬁ ne and treat pre-OA conditions. 
Th e acute ACL and meniscal injury popu lations are well 
suited for bench-to-bedside translational studies of new 
treatment strategies because they are more similar to 
popular animal models of pre-clinical OA such as ACL 
transection and meniscus injury than the more 
heterogeneous older human cohorts with established 
multi-site OA tradition ally used to evaluate potential 
disease-modifying treat ments [6].
Deﬁ ning and characterizing pre-OA in its earliest 
stages is crucial not only for understanding the disease 
process, but also for identifying potential disease-
modifying treatments and evaluating their eﬀ ectiveness. 
Early diagnosis will permit earlier treatment to modify 
the course of this disease. Th is review will focus on recent 
advances in imaging and biochemical biomarkers suitable 
for characterization of the pre-osteoarthritic joint.
Imaging of the pre-osteoarthritic joint
Radiographs have been used for more than a century to 
assist diagnosis of bone and joint disorders. Th e radio-
graphic hallmarks of structural changes in classic OA 
include osteophyte formation, joint-space narrowing, sub-
chondral bone thickening, and cyst formation. Clinical 
criteria of pain, stiﬀ ness, and age are poorly correlated to 
radiographic ﬁ ndings. Radiographic joint-space narrow ing, 
an indirect and highly insensitive measure of articular 
cartilage integrity, is the current standard by which 
clinical eﬃ  cacy of disease-modifying therapies for OA 
are measured [11]. Injuries to menisci, articular cartilage, 
and other joint structures readily apparent at arthroscopy 
or arthrotomy, as well as stress fractures and even early 
avascular necrosis, are not detectable by standard 
radiographic examination. Eﬀ orts to develop and assess 
disease-modifying treatments for OA have been 
hampered by the insensitivity of these traditional clinical 
and radiographic measures to joint-tissue health prior to 
the development of end-stage disease.
Advances in optical imaging and magnetic resonance 
imaging (MRI) have permitted direct imaging of joint 
tissues. Arthroscopy permits direct visualization and 
palpation of intra-articular structures. Th e sensitivity of 
MRI for soft tissue assessments and bone marrow 
changes exceeds that of conventional radiographs. While 
MRI lacks the tactile and dynamic examination capa-
bilities of arthroscopy, it permits noninvasive and quanti-
tative assessments of joint-tissue structure. As such, MRI 
oﬀ ers many advantages for diagnosis and staging of pre-
OA joints. While assessment of thin and geometrically 
com plex tissues such as articular cartilage remains 
challeng ing for MRI due to low resolution, newer 
techniques of quantitative, volumetric, and physio logic 
MRI show promise. Optical coherence tomo graphy 
(OCT), a new high-resolution imaging technology per-
mit ting micro scopic cross-sectional imaging of soft 
tissues in near real time, has been used arthroscopically 
as a translational research tool to assist in evaluating 
quantitative MRI of articular cartilage [12]. Finally, 
measuring joint synovitis reﬂ ects increasing recognition 
of an inﬂ ammatory compo nent in pre-OA conditions and 
in OA pathogenesis.
Arthroscopy and arthroscopic optical coherence 
tomography
Although the ﬁ rst known report of knee arthroscopy was 
presented in 1912 [13], only after key advances in ﬁ ber-
optic and video technologies occurred in the 1970s and 
1980s did arthroscopy became widely used for direct 
visualization, examination, and treatment of intra-articular 
soft tissues. Radiographically invisible patho logies such 
as meniscal tears, articular cartilage lesions, and cruciate 
ligament tears can be readily seen and palpated by 
arthroscopy. While subjective, the surgeon’s assessment 
of articular cartilage softening represents the earliest 
detectable clinical sign of pre-OA changes to articular 
cartilage known as chondromalacia or chondrosis 
(Figure 1) [14].
Conventional arthroscopy has continued fundamentally 
unchanged as a high-resolution surface imaging tech-
nology for which subsurface structure is inferred through 
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subjective palpation. In the past decade, OCT has been 
translated from bench to bedside to perform microscopic 
cross-sectional imaging of articular cartilage [12,15]. 
OCT provides high-resolution (4 to 20  μm) cross-
sectional imaging of articular cartilage that is comparable 
with low-power histology. Furthermore, OCT imaging 
does not involve ionizing radiation or risks of radiation 
exposure. Polarization-sensitive OCT detects changes in 
the polarization state of backscattered light and could be 
used to detect subsurface cartilage degeneration, because 
its associated collagen disorganization results in loss of 
polarization sensitivity [16]. Th is loss of birefringence has 
been seen in human cartilage both in vitro and in vivo [17].
For the characterization of pre-osteoarthritic clinical 
cohorts, OCT may complement conventional arthro-
scopy and quantitative magnetic resonance imaging 
(qMRI). A recent review discusses advantages of arthro-
scopic OCT for evaluation of subsurface cartilage abnor-
malities that may elude conventional arthroscopic surface 
imaging and MRI [18]. Comparison of OCT with MRI T2 
mapping and arthroscopy in human subjects with 
degenerative meniscal tears revealed that OCT can 
detect subsurface cartilage degeneration and is a useful 
translational clinical research tool. While no correlation 
was found between MRI T2 mapping and arthroscopy, 
OCT correlated with both techniques [12]. Th is was 
probably because OCT shared character istics of high 
resolution with arthroscopy and of cross-sectional 
quantitative data with MRI T2 mapping. OCT also 
detected early changes in articular cartilage that 
otherwise appears normal by gross inspection in bovine 
osteochondral cores following impact injury [19]. In 
evaluating the articular cartilage of human subjects 
following ACL injury, OCT shows microscopic sub-
surface changes suggestive of collagen matrix disruption 
(Figure 2).
Magnetic resonance imaging
MRI permits direct imaging of soft tissues. For evaluation 
of pre-OA conditions, conventional MRI permits 
morpho logical assessment of cartilage and meniscus, as 
well as other intra-articular and peri-articular soft 
tissues. Bone marrow changes are also well seen by 
conventional MRI. Subchondral bone attrition can be 
seen with MRI during early OA, but its signiﬁ cance is 
still poorly understood. A recent study shows that 
regional subchondral bone attrition is strongly associated 
with cartilage loss in the same region and may indicate 
areas of the knee joint experiencing great compressive 
stress [20]. Because OA development involves the whole 
joint, several semiquantitative grading scales for standard 
MRI have been developed, including the Whole Organ 
MRI score and the Boston Leeds Osteoarthritis Knee 
Score [21].
qMRI includes volumetric measurement and physio-
logic MRI. Advances in qMRI include development of 
high-ﬁ eld (3T) three-dimensional sequences such as 
double-echo steady state and fast low-angle shot [22]. 
Th ese sequences can detect cartilage volume and thick-
ness changes of only a few percent. Knee cartilage thick-
ness losses of <1% over 1  year have been identiﬁ ed in 
longitudinal volumetric assessments of 3T double-echo 
steady-state data acquired from at-risk subjects with pre-
radiographic OA or subjects with mild disease (Kellgren–
Lawrence score 1) enrolled in the Osteoarthritis Initiative 
study [23].
Physiologic quantitative MRI informs on 
subsurface structure and composition
Subsurface alterations to the biomolecular integrity of 
articular cartilage and menisci may represent the earliest 
structural changes in pre-OA conditions, but they cannot 
be reliably detected by clinical radiography or conven-
tional MRI [24]. Changes within the meniscus and deep 
layers of cartilage, where highly organized collagen ﬁ brils 
restrict proton mobility and cause rapid relaxation of the 
MRI signal, are particularly challenging to measure by 
conventional imaging techniques. Several reviews of 
qMRI techniques that address this challenge are already 
available [25]. Th is section will focus on qMRI evaluation 
Figure 1. Chondropathy and the modifi ed Outerbridge system. Sample arthroscopic images demonstrating diff erent grades of the modifi ed 
Outerbridge scoring system. (a) Grade 0: smooth, fi rm articular cartilage. (b) Grade 1: articular cartilage is surface-intact, but softened. (c) Grade 
2: articular cartilage with a damaged surface <50% of tissue depth. (d) Grade 3: articular cartilage with a damaged surface >50% of tissue depth. 
(e) Grade 4: articular cartilage with full-thickness tissue disruption extending to the subchondral bone.
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of changes to articular cartilage and menisci in pre-OA 
human subjects.
Physiologic quantitative MRI
Th e primary components of articular cartilage and 
menisci are water, type II collagen, and proteoglycans. 
Th e goals of physiologic qMRI are to detect biochemical, 
spatial, and relational changes of these components 
through quantifying MRI signal changes. While multiple 
technologies are under active investigation – including, 
but not limited to, sodium MRI for evaluation of matrix 
proteoglycans and diﬀ usion tensor MRI to measure 
tissue anisotropy – the primary physiologic qMRI 
techniques studied clinically in pre-OA cohorts include 
delayed gadolinium-enhanced magnetic resonance imag-
ing of cartilage (dGEMRIC) [26-28], T2 and T1rho 
mapping [29-31], and ultrashort echo-time enhanced T2* 
(UTE-T2*) mapping [32-34].
Delayed gadolinium-enhanced magnetic resonance 
imaging of cartilage
dGEMRIC is a technique used to map the relative con-
cen tration and spatial distribution of cartilage proteo-
glycan content [35]. Th e dGEMRIC index correlates with 
cartilage proteoglycan content and is decreased in OA, 
consistent with tissue glycosaminoglycan loss [35,36]. In 
early OA, lower dGEMRIC indices were seen in 
degenerated cartilage compartments compared with 
unaﬀ ected compartments [28]. Lower baseline dGEMRIC 
indices were found to predict OA disease presence in 
subjects with pre-radiographic OA [26]. Th e dGEMRIC 
index has also been shown to be potentially responsive to 
therapeutic interventions. Among meniscectomy subjects, 
examination of dGEMRIC before and after a 4-month 
change in exercise regimen found that subjects who 
increased their exercise level experienced a concurrent 
increase in the dGEMRIC index, indicating increased 
glycosaminoglycan content [27].
T2 mapping
T2 is sensitive to tissue hydration and collagen matrix 
organization. Previous studies have established that 
regional variations in cartilage matrix architecture result 
in signiﬁ cant variation in T2 values with articular carti-
lage depth and in cartilage across diﬀ erent regions of the 
knee [37,38]. Despite spatial variations, T2 values 
typically increase with cartilage degeneration. In early 
disease and in subjects at risk for developing OA, T2 has 
been shown to be focally elevated [39]. Longitudinal T2 
has also been shown to change with activity. Light 
exercise in menis cec tomy subjects at risk of developing 
OA was signiﬁ  cantly associated with a decrease in T2 
values compared with sedentary subjects or strenuous 
exercisers, suggesting a chondroprotective eﬀ ect of low-
intensity activities [29]. In females after meniscectomy, 
moderate and strenuous exercise (for example, running, 
cycling) was associated with elevated T2 values, suggest-
ing cartilage degeneration with more intense exercise 
[29].
T1rho mapping
Like T2, T1rho is thought to be sensitive to tissue 
hydration and matrix macromolecular architecture [30]. 
Unlike T2, T1rho may also be sensitive to the proteo-
glycan content of the tissue; however, this point remains 
controversial [40]. Cartilage T1rho values generally tend 
to be higher in mild OA subjects compared with controls, 
but reports of a larger range and eﬀ ect size for T1rho 
compared with T2 indicate that T1rho may be more 
sensitive to cartilage degeneration [30]. Further work is 
needed to illuminate the relative strengths and 
weaknesses of T2 and T1rho as qMRI techniques for 
evaluating early OA.
Ultrashort echo-time enhanced T2* mapping
UTE-T2* imaging is a novel technique with the potential 
to measure short-T2 MRI signals from the meniscus and 
Figure 2. Optical coherence tomography. Optical coherence tomography (OCT) permits cross-sectional imaging of articular cartilage at 
resolutions comparable with low-power histology. (a) Arthroscopically fi rm and surface-intact cartilage shows OCT form birefringence. (b) Loss of 
birefringent banding on OCT correlates to softened cartilage. (c) Subsurface voids and fi ssures can be visualized with OCT.
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the deep layers of articular cartilage that are not well 
captured by conventional MRI or by standard T2 
mapping. In vitro, UTE-T2* values have been shown to 
reﬂ ect collagen matrix integrity of human articular 
cartilage explants as determined by polarized light 
micro scopy [41]. In vivo, UTE-T2* mapping is repro-
ducible and shows quantitative subsurface changes to 
surface-intact articular cartilage and menisci in human 
subjects acutely following ACL injury (Figure 3).
MRI of bone marrow, menisci and synovium in 
pre-osteoarthritis
While both structural MRI and qMRI of thin, anisotropic, 
and geometrically complex articular cartilage remain a 
challenge even using high-ﬁ eld magnets, information 
concerning pathological changes to other joint structures 
implicated in joint degeneration such as bone marrow, 
menisci, and synovium is more readily obtained from 
conventional MRI. qMRI of menisci is a newer area of 
investigation that may also inform on subclinical 
meniscal injury and pathology.
Bone marrow lesions
Bone bruises and bone marrow lesions (BML) are 
commonly seen in traumatic joint injuries, in areas of 
cartilage loss, and following meniscal root tears. Because 
these injuries place aﬀ ected joints at risk for accelerated 
OA, assessment of BML may be useful for evaluating pre-
OA states. BML and bone marrow edema appear on MRI 
as areas of low signal intensity on T1-weighted images, 
and corresponding high signal intensity on T2-weighted 
images [42]. MRI is useful for assessing the presence and 
severity of BML, and for elucidating their relationships 
with early OA development.
Recent studies suggest that BML correlate spatially 
with cartilage degeneration and that BML may be an 
imaging marker for subsequent OA development. 
Correlation was found between joint eﬀ usions and BML 
[43]. BML have been associated with higher T1rho MRI 
values in articular cartilage adjacent to the bony edema 
[44]. Strong corre lations were also found between BML 
and development of subchondral bone attrition [45].
Meniscus
Meniscus injury and degeneration play substantial roles 
in the development of knee OA. Loss of meniscus 
function, whether through trauma or degeneration, leads 
to accelerated joint degeneration. A recent study showed 
that complex meniscal tears were associated with 
elevated T2 relaxation times in the adjacent tibial 
cartilage [46]. Medial meniscus tear is common in the 
ACL-injured knee, and accelerated OA development is 
more common following combined ACLT and medial 
meniscus tear than isolated ACLT [6].
In recognition of the role of meniscus pathology in pre-
OA, researchers have begun to examine the signiﬁ cance 
of intrasubstance MRI signal changes within the menisci, 
and whether these changes are associated with OA 
development [47]. Although menisci are typically 
assessed with structural MRI, semi-qMRI metrics may be 
useful for evaluating meniscal health, particularly in pre-
OA. Using novel UTE-T2* mapping, menisci without 
evidence of tear by structural MRI or arthroscopy in 
humans with ACLT showed elevated T2*, suggesting 
subsurface matrix injury (Figure 3) [34].
Meniscal damage may trigger synovial activation, 
thereby aﬀ ecting overall joint health. Evaluation of sub-
jects without radiographic signs of OA in the Framing-
ham and MOST studies showed that joint eﬀ usions were 
more prevalent in those patients with meniscal tears than 
in those without meniscal pathology [48]. Th is obser-
vation held even in knees with no MRI evidence of 
articular cartilage changes. Th ese results further support 
the importance of meniscus assessment in identiﬁ cation 
of pre-osteoarthritic knees.
Synovitis
Assessment of synovitis may be important for the 
characterization and early treatment of pre-OA condi-
tions. Synovitis has traditionally been considered a 
hallmark of inﬂ ammatory arthritis and less relevant to 
clinical OA. At total knee replacement for end-stage OA, 
however, synovitis was observed in >90% of patients  – 
with nearly one-third showing severe inﬂ ammation, 
including histological evidence of lymphoid aggregates 
[49,50]. In human subjects with pre-OA conditions, 
synovitis is evident in synovial biopsies [51,52]. While 
both MRI and ultrasound have been used to non-
invasively assess inﬂ ammation in osteoarthritic joints, 
MRI shows promise in systematic evaluation of synovitis 
along with evaluation of BML, menisci, and articular 
cartilage. A high prevalence of synovitis has been shown 
in people with knee OA, using both contrast-enhanced 
MRI and noncontrast MRI [53,54].
Validation
Imaging biomarkers, including OCT and physiologic 
MRI metrics, have been evaluated in a number of 
preclinical animal studies and in vitro studies with human 
cartilage. Strong correlations between OCT and histo-
morphometric analysis of cartilage repair tissue was 
established in rabbits [55], while split-line analyses and 
polarized light microscopy validated polarization-sensi-
tive OCT detection of the three-dimensional structure of 
articular cartilage collagen matrix in equine fetlock joints 
[56]. MRI detection of cartilage lesions with dGEMRIC 
was shown to correspond to zones of mechanically intact 
cartilage with low proteoglycan content, as determined 
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by azan-stained histologic sections obtained from human 
knees during total knee replacement. In both bovine and 
human explant studies, the dGEMRIC index was shown 
to correspond to histological assessments of proteoglycan 
content [57,58]. In a separate study, proteoglycan deple-
tion due to trypsinization of bovine patellar cartilage was 
found to correspond to signiﬁ cant increases in T1rho 
[59]. Ex vivo studies have correlated OCT with T2 and 
polarized microscopy, μMRI T2 with polarized micro-
scopy, and UTE-T2* with collagen architecture as assessed 
by polarized microscopy [41,60,61]. Human cartilage 
removed during total knee replacement had high T2 and 
T1rho values and showed ﬁ brillation by histology when 
compared with intact cartilage [57].
While human tissue and animal studies inform on 
imaging metrics, true validation requires human in vivo 
study. In a level I clinical diagnostic study, OCT was 
shown to correlate with arthroscopy while MRI T2 maps 
correlated with OCT [12]. Th e reliability of dGEMRIC as 
an indicator of proteoglycan content in deep cartilage 
when used clinically remains unclear, with several human 
clinical studies suggesting incomplete penetration of the 
contrast agent into deep articular cartilage [58,62]. In 
human studies, T1rho continues to prove sensitive to 
early OA, but more work is required to understand and 
demonstrate its speciﬁ city for molecular changes to the 
proteoglycan and/or collagen components of articular 
cartilage [40]. Similarly, because cartilage T2 reﬂ ects 
tissue hydration, collagen organization, and collagen 
ﬁ bril integrity, interpretation of T2 change in clinical 
studies remains diﬃ  cult [40,63]. Recently, UTE-T2* 
mapping was shown to be potentially sensitive to 
subclinical meniscus damage in ACL-injured subjects 
[34]. Because new imaging technologies are employed 
with the goal of detecting pathological changes that 
escape current clinical detection using technologies 
accepted as current clinical standards, longitudinal 
clinical studies will be needed to see whether potential 
imaging markers of early disease show predictive value.
Biomarkers
Metabolic changes in articular cartilage, synovium, and 
subchondral bone may represent the earliest measurable 
changes in pre-OA conditions. Metabolic perturbations 
are frequently considered reversible. As such, identi ﬁ -
cation and validation of biomarkers for pre-OA states 
and at-risk joints may have wide application in clinical 
trials of new intervention strategies, in routine screening, 
as well as in activity-modiﬁ cation programs and return-
to-play evaluations.
Characteristics of OA development include progressive 
loss of articular cartilage and increasing inﬂ ammation. 
Th ese pathological states have been observed in various 
experimental animal models of OA, including meniscal 
destabilization and ACL transection. Advantages of 
studying biochemical biomarkers in animal models of 
OA include availability of biospecimens before injury and 
at precise intervals after injury where biomarker data 
can be correlated with structural information obtained 
from gross and histological evaluations. Biomarkers of 
cartilage matrix synthesis and degradation were found to 
be elevated during the early phases of experimental OA 
using the canine ACL transection model [64]. Structural 
changes to cartilage, bone, and menisci following ACLT 
and sham surgery in an ovine model were similarly 
shown to be highly correlated to inﬂ ammatory and 
Figure 3. Ultrashort echo-time enhanced T2* maps of cartilage and meniscus show changes after knee injury. Ultrashort echo-time 
enhanced T2* (UTE-T2*) maps of articular cartilage and meniscus tissue show quantitative diff erences between (a) an uninjured asymptomatic 
subject and (b) an anterior cruciate ligament-injured subject with concomitant posterolateral meniscus pathology.
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degradative synovial biomarkers [65]. Th ese and other 
preclinical studies of surgically induced joint injuries 
show promise in the use of biochemical biomarkers of 
joint-tissue turnover and inﬂ ammation for early 
detection and staging of pathological changes associated 
with later OA development.
In humans, however, the development and validation of 
biomarkers in traditional cohorts consisting of older 
individuals with clinical OA has been challenging, 
particularly due to variable disease states and multi-joint 
involvement. Th e challenge has been compounded by the 
insensitivity of traditional clinical outcome measures 
such as radiographs to structural and metabolic changes, 
as well as the poor correlation between clinical symptoms 
and radiographic changes, especially in early disease. 
Closing the apparent gap between the preclinical ﬁ ndings 
and clinical studies can be potentially eﬀ ected through 
study of biomarkers in human clinical cohorts more 
similar to the animal models of surgical joint injury 
induced OA [6]. Speciﬁ cally, systematic longitudinal 
evalu ations of biochemical biomarkers following ACL 
and meniscus injury in human clinical cohorts that are 
also followed by structural and clinical outcome 
measures are needed. A subset of biomarkers derived 
from the degradation and formation of articular cartilage 
has been used for OA detection, and reviews of bio-
markers in OA have been recently published [66,67]. As 
such, this review will focus on recent research assessing 
biomarkers for pre-OA conditions, especially following 
ACL and meniscus injuries.
Infl ammatory cytokines and mediators
Inﬂ ammation is present following joint injury and its 
role is increasingly recognized in OA development. 
Inﬂ ammatory mediators may be useful indicators of 
early and chronic metabolic changes in the joint. 
Previous studies showed that inﬂ ammatory mediators 
increase in the synovial ﬂ uid after ACL injury, with 
concentrations peaking early and decreasing over time 
[68,69]. A recent study showed that synovial ﬂ uid C-
reactive protein transiently increased following ACL 
injury, but decreased from the initial peak within 
3 months. In contrast, no substantive changes in IL-1B 
levels were found among the study’s 11 participants 
[70]. In another study, higher concentrations of IL-6, 
IFNγ, MIP-1β, and MCP-1 were measured in the 
synovial ﬂ uid of ACL-injured patients versus uninjured 
controls [71]. Synovial biomarkers from meniscus-
injured populations, including both acute and chronic 
injury, had higher levels of cytokines IFNγ, IL-6, MCP-1, 
MIP-1β, IL-2, IL-4, IL-10, and IL-13 compared with 
asymptomatic populations with IL-6, MCP-1, MIP-1β, 
and IFNγ concentrations correlating with patient-
reported pain outcome scores [72].
Th ese studies demonstrate that inﬂ ammatory media-
tors transiently increase following acute ACL injury, with 
levels decreasing over time. Th e data from meniscus-
injured subjects suggest persistence or resurgence of 
inﬂ ammation, especially in those with pain. Th ese data 
support the need for continued longitudinal assessment 
of inﬂ ammatory mediators in joint-injured cohorts as 
potential biomarkers for diagnosis and staging of pre-
osteoarthritic conditions.
Collagen and bone metabolites
Byproducts of articular cartilage and bone metabolism 
were some of the ﬁ rst biomarkers assessed [73]. Early 
studies focused on biochemical biomarkers in popu-
lations with radio graphic OA, typically in patients with 
Kellgren–Lawrence score 2 or higher. Recent studies of 
the synovial ﬂ uid in subjects with ACLT show that 
elevations of C-terminal cross-linked telopeptide type I 
and type II collagen, N-terminal telopeptides of type I 
collagen, and C1,2C – all biomarkers of collagen 
turnover  – peak several weeks after injury [70]. Th ere 
was also an increase in biomarkers associated with bone 
resorption. In the same study, strong correlations were 
found between serum and synovial ﬂ uid concentrations 
of bone metabolism biomarkers [70]. Th is study has 
reﬁ ned the potential utility of biochemical biomarkers of 
cartilage and bone metabolism in early OA; however, 
further studies are needed.
Glycosaminoglycans and hyaluronic acid
Proteoglycans are important articular cartilage matrix 
components considered sensitive to changes in cartilage 
homeostasis [74,75]. Glycosaminoglycan and aggrecan 
ARGS fragments have been found to be transiently 
elevated in the synovial ﬂ uid of ACL-injured patients 
[76,77]. Aggrecan fragment ARGS-SELE remains elevated 
for at least 2  years after injury [76]. Serum is easier to 
obtain than synovial ﬂ uid and is of particular interest in 
biomarker analysis for screening purposes and for 
longitudinal studies. In a recent study, the concen tration 
of W6F (a chondroitin sulfate epitope) was higher in the 
serum of ACL-injured subjects compared with uninjured 
controls [78]. Appropriate analysis of serum biomarkers 
probably cannot be per formed in isolation because the 
detected concentra tions represent processes within the 
entire body, while synovial ﬂ uid is more reﬂ ective of 
metabolism within the aﬀ ected joints. Th ese studies show 
promise in the use of bio chemical biomarkers, 
particularly synovial ﬂ uid analysis, to charac terize joint 
changes following ACL and meniscus injury. Analyses of 
serum, urine, and synovial ﬂ uid from these cohorts in 
conjunction with advanced structural imaging have the 
potential to yield candidate biomarkers that can be used 
for characterization of other pre-OA states.
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Conclusion
OA is a prevalent, disabling disease that currently lacks 
disease-modifying treatments. Clinical OA typically 
develops over decades and is strongly associated with 
modiﬁ able factors such as joint injury, obesity, and 
mechanical overload. Th e ability to detect pre-osteo-
arthritic changes prior to the onset of irreversible 
changes is crucial for understanding the disease process, 
identifying potential disease-modifying treatments, and 
evaluating the eﬀ ective ness of new therapies. Compre-
hensive longitudinal studies of joint-injured cohorts 
allow for characterization of the earliest stages of joint 
degeneration, thereby maximizing opportunities for 
development and validation of bio chemical and imaging 
biomarkers and for early inter vention. Th e validation of 
tools suitable for diagnosis and staging of joint injury and 
early degeneration is needed to support a paradigm shift 
towards early treatment of pre-osteoarthritic conditions 
as a strategy to prevent or delay the onset of classic OA.
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